Oustanding shares and voting rights

(Article L. 233-8 II du Code de commerce, art. 55 de loi)

Date  Number of shares                      Number of theoretical voting rights
31 May 2017 131 077 601 138 980 348
30 April 2017 127 158 554 135 044 557
31 March 2017 127 158 554 135 045 233
28 February 2017 116 415 854 124 267 670
31 January 2017 116 415 854  124 274 214

 * 750,000 shares issued as part of the Equity Line
** 2,000,000 shares issued as part of the Equity Line [see the press release of 25/02/2016]
As part of the Equity Line contract, 2,750,000 shares in total have been issued for a gross amount of €1,405,00 i.e. an average price of €0.51/share.

Tracking the number of shares outstanding

This chart (in French) tracks the number of outstanding shares in connection with the flexible bond financing (OCABSA) as discribed in the press release fo 21/07/2016.

See the chart of shares oustanding in connection with OCABSA

 

See information for the year 2016

See information for the year 2015

See information for the year 2014

See information for the year 2013

See information for the year 2012

See information for the previous years (2010 and 2011)

 

 

 

 

 

Stock Exchange Contact

Any financial question

Given the number of calls and regulatory constraints, the company is sorry to inform shareholders that it is no longer able to individually answer incoming calls. Thank you to address any questions via email to contactbourse@europlasma.com.